Today in AI

The day in tech, in order.

A catch-up day: Google retires Jules, Claude drops its 5-hour cap for Ultra, and Anthropic turns out to be SpaceX's biggest customer.

November 1, 2026 · 7 stories

  1. MorningPolicy

    OpenAI, Google, Microsoft and Anthropic back one robots.txt AI-training opt-out

    A shared __usage_ai-training token lets publishers opt out of AI training across the labs at once; rollout is staggered and the draft is not yet a formal standard.

    Source: Skimwire
  2. AfternoonTraction

    Anthropic is reportedly SpaceX's biggest customer, at 34.5% of Q3 revenue

    Bloomberg reports the mystery 'Customer B' in SpaceX's filing is Anthropic, overtaking the US government; neither company has confirmed the identification.

    Source: BusinessToday
  3. AfternoonTraction

    New AI computing capacity is doubling every 9 months, Epoch AI estimates

    Chips sold in Q2 2026 added about 6.3 million H100-equivalents of compute, up from 0.8 million in early 2024; Nvidia still supplies most of it.

    Source: Pivot News
  4. AfternoonPolicy

    Google shuts down Jules and folds it into Antigravity

    Jules goes read-only on November 11 and offline December 31, 2026; Google says its background-coding lessons move into Antigravity, with no automatic migration.

    Source: Gadgets Now
  5. AfternoonFeatures

    Claude Max 20x becomes Ultra and drops the 5-hour limit for verified accounts

    Prices stay at $100 (Max) and $200 (Ultra); verified Ultra accounts keep only the 10x Pro weekly cap, while newer accounts keep a temporary limit until verified.

    Source: Notebookcheck
  6. AfternoonFeatures

    Anthropic extends Claude text watermarking to four older models on November 3

    Mythos 5, Opus 4.7, Opus 4.6 and Sonnet 4.6 gain the invisible word-choice watermark, reported via a customer email; detection stays in private preview.

    Source: TechProlonged
  7. EveningLaunch

    Musk says Neuralink's Blindsight is engineering-ready and awaits regulators

    Musk's X post claims the vision implant is ready from an engineering standpoint; no human Blindsight results have been disclosed and FDA clearance is still pending.

    Source: Gadgets Now

Timelines are composed each morning from the previous day's verified news — every story links to the source it was checked against. See the full feed on the news page.